melatonin has been researched along with 5-methoxycarbonylamino-n-acetyltryptamine in 19 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 10 (52.63) | 29.6817 |
| 2010's | 9 (47.37) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Berthelot, P; Boutin, JA; Caignard, DH; Chavatte, P; Delagrange, P; Ettaoussi, M; Klupsch, F; Lesieur, D; Péres, B; Renard, P; Yous, S | 1 |
| Du, H; Hu, Z; Wang, J; Zhang, X | 1 |
| Berthelot, P; Boutin, JA; Caignard, DH; Delagrange, P; Ettaoussi, M; Farce, A; Leclerc, V; Rami, M; Renard, P; Yous, S | 1 |
| Beznos, OV; Chesnokova, NB; Lozinskaya, NA; Volkova, MS; Zaryanova, EV; Zefirov, NS | 1 |
| Delagrange, P; Kopp, C; Misslin, R; Rettori, M; Vogel, E | 1 |
| Hoyle, CH; Martin, L; Pelaez, T; Peral, A; Pintor, J | 1 |
| Dubocovich, ML; Farsky, SH; Lopes, C; Lotufo, CM; Markus, RP | 1 |
| Berger, E; Fauteck, JD; Musshoff, U; Riewenherm, D; Speckmann, EJ | 1 |
| Hoyle, CH; Peláez, T; Peral, A; Pintor, J | 1 |
| Delagrange, P; Hammad, H; O'Rourke, ST; Scalbert, E; Vanhoutte, PM | 1 |
| Alarma-Estrany, P; Crooke, A; Peral, A; Pintor, J | 1 |
| Sampaio, Lde F | 1 |
| Ikeda, M; Kojima, S; Tohei, A | 1 |
| Alarma-Estrany, P; Guzman-Aranguez, A; Huete, F; Pelaez, T; Peral, A; Pintor, J; Plourde, R; Yerxa, B | 1 |
| Dortch-Carnes, J; Tosini, G | 1 |
| Crooke, A; Huete-Toral, F; Martín-Gil, A; Martínez-Águila, A; Pintor, J | 1 |
| Allemandi, D; Andrés-Guerrero, V; Herrero-Vanrell, R; Molina-Martínez, IT; Palma, S; Quinteros, D; Vicario-de-la-Torre, M | 1 |
| Crooke, A; Huete-Toral, F; Martínez-Águila, A; Pintor, J | 1 |
| Fonseca, B; Martínez-Águila, A; Pérez de Lara, MJ; Pintor, J | 1 |
19 other study(ies) available for melatonin and 5-methoxycarbonylamino-n-acetyltryptamine
| Article | Year |
|---|---|
Design and synthesis of benzofuranic derivatives as new ligands at the melatonin-binding site MT3.
Topics: Binding Sites; Dose-Response Relationship, Drug; Drug Design; Inhibitory Concentration 50; Ligands; Melatonin; Molecular Structure; Receptors, Melatonin; Stereoisomerism; Structure-Activity Relationship; Tryptamines | 2008 |
A novel quantitative structure-activity relationship method to predict the affinities of MT3 melatonin binding site.
Topics: Algorithms; Benzofurans; Binding Sites; Indoles; Ligands; Linear Models; Melatonin; Models, Chemical; Molecular Structure; NAD(P)H Dehydrogenase (Quinone); Naphthalenes; Predictive Value of Tests; Quantitative Structure-Activity Relationship; Receptors, Melatonin | 2008 |
Design and synthesis of naphthalenic derivatives as new ligands at the melatonin binding site MT3.
Topics: Binding Sites; Drug Design; Ligands; Melatonin; Molecular Structure; Naphthalenes; Receptors, Melatonin; Stereoisomerism; Structure-Activity Relationship | 2011 |
Oxindole-based intraocular pressure reducing agents.
Topics: Crystallography, X-Ray; Dose-Response Relationship, Drug; Enzyme Inhibitors; Humans; Indoles; Intraocular Pressure; Ligands; Models, Molecular; Molecular Structure; Oxindoles; Quinone Reductases; Structure-Activity Relationship; Time Factors | 2017 |
Anxiolytic-like properties of melatonin receptor agonists in mice: involvement of mt1 and/or MT2 receptors in the regulation of emotional responsiveness.
Topics: Analysis of Variance; Animals; Anti-Anxiety Agents; Behavior, Animal; Dose-Response Relationship, Drug; Exploratory Behavior; Heterocyclic Compounds, 2-Ring; Male; Melatonin; Metallothionein 3; Mice; Mice, Inbred C3H; Receptors, Cell Surface; Receptors, Cytoplasmic and Nuclear; Receptors, Melatonin; Serotonin; Tryptamines | 2000 |
Involvement of melatonin MT(3) receptors in the regulation of intraocular pressure in rabbits.
Topics: Animals; Dose-Response Relationship, Drug; Intraocular Pressure; Male; Melatonin; Rabbits; Receptors, Cell Surface; Receptors, Cytoplasmic and Nuclear; Receptors, Melatonin; Time Factors; Tryptamines | 2001 |
Melatonin and N-acetylserotonin inhibit leukocyte rolling and adhesion to rat microcirculation.
Topics: Animals; Arterioles; Blood Flow Velocity; Cell Adhesion; Dose-Response Relationship, Drug; Leukocytes; Male; Melatonin; Microcirculation; Rats; Rats, Wistar; Serotonin; Tetrahydronaphthalenes; Tryptamines | 2001 |
Melatonin receptors in rat hippocampus: molecular and functional investigations.
Topics: Animals; Circadian Rhythm; Electrophysiology; Hippocampus; Male; Melatonin; Membrane Potentials; Oocytes; Organ Culture Techniques; Rats; Rats, Wistar; Receptors, Cell Surface; Receptors, Cytoplasmic and Nuclear; Receptors, Melatonin; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tetrahydronaphthalenes; Tryptamines; Xenopus | 2002 |
Ocular hypotensive effects of melatonin receptor agonists in the rabbit: further evidence for an MT3 receptor.
Topics: Animals; Dose-Response Relationship, Drug; Male; Melatonin; Ocular Hypotension; Rabbits; Receptors, Cell Surface; Receptors, Cytoplasmic and Nuclear; Receptors, Melatonin; Tryptamines | 2003 |
Melatonin inhibits nitrate tolerance in isolated coronary arteries.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Arteries; Coronary Vessels; Cromakalim; Dose-Response Relationship, Drug; Endothelium, Vascular; In Vitro Techniques; Isometric Contraction; Isoproterenol; Melatonin; Muscle, Smooth, Vascular; Naphthalenes; Nitrates; Nitroglycerin; Receptors, Melatonin; Swine; Tachyphylaxis; Time Factors; Tryptamines; Vasoconstriction; Vasodilation; Vasodilator Agents | 2003 |
Requirement of intact sympathetic transmission for the ocular hypotensive effects of melatonin and 5-MCA-NAT.
Topics: Adrenergic Uptake Inhibitors; Animals; Central Nervous System Depressants; Dose-Response Relationship, Drug; Drug Interactions; Male; Melatonin; Ocular Hypertension; Oxidopamine; Rabbits; Reserpine; Sympathectomy, Chemical; Sympathetic Nervous System; Sympatholytics; Tryptamines; Vesicular Monoamine Transport Proteins | 2007 |
An unexpected effect of 5-MCA-NAT in chick retinal development.
Topics: Aging; Animals; Binding Sites; Chick Embryo; Chickens; Colforsin; Cyclic AMP; Dose-Response Relationship, Drug; Melatonin; Neurogenesis; Neurons; Organ Culture Techniques; Organogenesis; Quinone Reductases; Receptors, G-Protein-Coupled; Receptors, Melatonin; Retina; Second Messenger Systems; Tryptamines; Up-Regulation | 2009 |
Melatonin inhibits tachykinin NK₂ receptor-triggered 5-HT release from guinea pig isolated colonic mucosa.
Topics: Animals; Colon; Guinea Pigs; Hydroxyindoleacetic Acid; In Vitro Techniques; Intestinal Mucosa; Melatonin; Neurokinin A; Peptide Fragments; Prazosin; Receptors, Melatonin; Receptors, Neurokinin-2; Serotonin; Tryptamines | 2011 |
Design of novel melatonin analogs for the reduction of intraocular pressure in normotensive rabbits.
Topics: Animals; Dose-Response Relationship, Drug; Drug Design; Eye; Glaucoma; Intraocular Pressure; Isoindoles; Melatonin; Ocular Hypertension; Rabbits; Receptor, Melatonin, MT2; Receptors, Melatonin; Structure-Activity Relationship; Time Factors; Tryptamines | 2011 |
Melatonin receptor agonist-induced reduction of SNP-released nitric oxide and cGMP production in isolated human non-pigmented ciliary epithelial cells.
Topics: Aqueous Humor; Cells, Cultured; Ciliary Body; Colorimetry; Cyclic GMP; Epithelial Cells; Humans; Immunoassay; Intraocular Pressure; Isoindoles; Melatonin; Nitric Oxide; Nitroprusside; Receptor, Melatonin, MT1; Receptor, Melatonin, MT2; Receptors, Melatonin; Tryptamines | 2013 |
Melatonin and its analog 5-methoxycarbonylamino-N-acetyltryptamine potentiate adrenergic receptor-mediated ocular hypotensive effects in rabbits: significance for combination therapy in glaucoma.
Topics: Adrenergic Agonists; Adrenergic alpha-2 Receptor Agonists; Adrenergic beta-Antagonists; Animals; Cells, Cultured; Ciliary Body; Drug Synergism; Epithelial Cells; Gene Expression Regulation; Glaucoma; Intraocular Pressure; Male; Melatonin; Nerve Tissue Proteins; Neuroprotective Agents; Ocular Hypotension; Ophthalmic Solutions; Rabbits; Receptors, Adrenergic, alpha-2; Receptors, Adrenergic, beta-2; Tryptamines | 2013 |
Hybrid formulations of liposomes and bioadhesive polymers improve the hypotensive effect of the melatonin analogue 5-MCA-NAT in rabbit eyes.
Topics: Adhesives; Animals; Antihypertensive Agents; Chemistry, Pharmaceutical; Drug Liberation; Hydrogen-Ion Concentration; Intraocular Pressure; Liposomes; Male; Melatonin; Osmolar Concentration; Particle Size; Polymers; Rabbits; Tears; Tryptamines; Viscosity | 2014 |
Melatonin receptors trigger cAMP production and inhibit chloride movements in nonpigmented ciliary epithelial cells.
Topics: Animals; Cell Line; Chlorides; Ciliary Body; Cyclic AMP; Epithelial Cells; Melatonin; Movement; Rabbits; Receptors, Adrenergic, alpha-1; Receptors, Melatonin; Second Messenger Systems; Tryptamines | 2015 |
Effect of Melatonin and 5-Methoxycarbonylamino-N-Acetyltryptamine on the Intraocular Pressure of Normal and Glaucomatous Mice.
Topics: Animals; Dose-Response Relationship, Drug; Glaucoma; Intraocular Pressure; Melatonin; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Receptor, Melatonin, MT2; Tetrahydronaphthalenes; Tryptamines | 2016 |